CIK 0001773751
- Large accelerated filer
Hims & Hers Health, Inc.
Sign in to watch- Ticker
- HIMS
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-851-0195
- Business address
- 2269 CHESTNUT ST, #523, SAN FRANCISCO, CA, 94123
- Former names
- Oaktree Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,483,933
- in 10 filings, $2.5M under 10b5-1 plans
Net −$2,483,933. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-05 | Chi Michael Chief Commercial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −28,776 | 15,000 | ||
| 2025-05-28 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion 10b5-1 | +6,437 | $5.01 | $32K | 120,253 |
| 2025-05-28 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −11,581 | $52.98 | $614K | 39,153 |
| 2025-05-28 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −6,437 | 386,970 | ||
| 2025-05-27 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −3,233 | $55.87 | $181K | 153,194 |
| 2025-05-22 | Becklund Irene PAO | Sale 10b5-1 | −5,071 | $53.51 | $271K | 0 |
| 2025-05-19 | Kabbani Nader Chief Operating Officer | Grant or award · Restricted Stock Unit | +216,333 | 216,333 | ||
| 2025-05-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −2,792 | $59.27 | $165K | 89,311 |
| 2025-05-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −25,307 | $57.86 | $1.5M | 307,421 |
| 2025-05-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −22,227 | $58.70 | $1.3M | 285,194 |
| 2025-05-16 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +17,001 | $2.43 | $41K | 106,312 |
| 2025-05-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −17,001 | $58.72 | $998K | 89,311 |
| 2025-05-16 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +108,334 | $2.43 | $263K | 197,645 |
| 2025-05-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −49,265 | $57.84 | $2.8M | 148,380 |
| 2025-05-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −52,642 | $58.67 | $3.1M | 95,738 |
| 2025-05-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −6,427 | $59.21 | $381K | 89,311 |
| 2025-05-16 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −17,001 | 102,010 | ||
| 2025-05-16 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −108,334 | 973,065 | ||
| 2025-05-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −548 | 63,784 | ||
| 2025-05-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −5,889 | 393,407 |
Page 34 of 37 · 739 trades